InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Krause Kevin Michael. Director active across 1 company, notably AN2 Therapeutics, Inc.. In total, 4 disclosures have been logged. History available since 2 January 2024. The latest transaction was filed on 15 March 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations